Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
49.20    -1.35 (-2.67%)
Bid:
48.40
Ask:
50.00
Spread: 1.60 (3.306%)
Market Cap: £188.15m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Issue of Equity

30 Jan 2025 09:00

RNS Number : 1564V
British Smaller Companies VCT2 Plc
30 January 2025
 

British Smaller Companies VCT2 plc (the "Company")

Issue of Equity

On 17 October 2024 British Smaller Companies VCT2 plc and British Smaller Companies VCT plc (together the "Companies") launched offers for subscription (the "Offers") seeking to initially raise £50 million in aggregate for the 2024/25 tax year, with an over-allotment facility of £25 million, which was subsequently utilised in full. The Offers were closed to new applications on 8 January 2025.

The Company announces that today, 30 January 2025, it has made the first issue of ordinary shares pursuant to the Offers by allotting 17,313,531 ordinary shares of 0.01 pence each, raising gross proceeds of £9.8 million. This allotment was made in respect of the tax year 2024/25. In accordance with the pricing formula set out in the Prospectus, the new ordinary shares were allotted at offer prices of between 55.96 pence and 58.72 pence per share depending on the adviser charge (if applicable) and the number of shares issued pertaining to each application. Applicants received additional New Shares equivalent to receiving a 3.35 per cent per annum rate of return on funds awaiting allotment, calculated by reference to the number of days between the acceptance of an Application (including full receipt of cleared funds) and the date of allotment.

The net asset value ("NAV") used for the calculation of the issue price on 30 January 2025 is the last reported NAV of 54.85 pence per ordinary share, being the unaudited NAV as at 30 September 2024 of 57.35 pence per ordinary share, adjusted for the interim dividend of 1.50 pence per ordinary share paid on 1 November 2024 and the special dividend of 1.00 pence per ordinary share paid on 27 January 2025.

Together, the Companies have in total allotted shares relating to gross proceeds of £25.0 million under the Offers, of which £9.8 million has been raised by the Company and £15.2 million has been raised by British Smaller Companies VCT plc.

In this allotment Roger McDowell, non-executive Director of the Company, has been allotted 88,867 ordinary shares of 0.01 pence in the Company, bringing his aggregate total holding to 926,126 ordinary shares.

In this allotment the employees and members of the Manager, YFM Private Equity Limited, have been allotted 40,004 ordinary shares of 0.01 pence each in the Company, bringing their aggregate total holding to 864,570 ordinary shares.

Applications are now being made by the Company for the ordinary shares which were allotted on 30 January 2025 to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities. Dealings are expected to commence on or around 13 February 2025.

The Companies have issued a prospectus relating to the Offers (the "Prospectus"). The proceeds will be allocated between the Companies in accordance with the terms set out in the Prospectus.

The second and final allotment of the Offers is expected to take place between 1 - 4 April 2025.

Following the allotment of 17,313,531 ordinary shares, the Company's issued share capital consists of 299,176,349 ordinary shares with voting rights ("Voting Capital") and 28,770,963 shares held in treasury.

The above statement of Voting Capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

30 January 2025

For further information, please contact:

Marcus Karia YFM Equity Partners Tel: 0113 244 1000

Alex Collins Panmure Liberum Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFSFLIIAFIE
Date   Source Headline
25th Oct 202112:08 pmRNSPayment of Dividend and Issue of Equity
19th Oct 202110:14 amRNSNet Asset Value and Dividend Re-investment Scheme
11th Oct 20217:51 amRNSOffer Update
11th Oct 20217:49 amRNSOffer Update
7th Oct 20212:30 pmRNSInterim Dividend
28th Sep 20217:00 amRNSTransaction in Own Shares
27th Sep 20211:11 pmRNSOffer Update
27th Sep 20211:10 pmRNSOffer Update
24th Sep 202112:58 pmRNSOffer Update
24th Sep 202112:57 pmRNSOffer Update
22nd Sep 202112:00 pmRNSPublication of a Prospectus
22nd Sep 202112:00 pmRNSPublication of a Prospectus
10th Sep 20213:25 pmRNSHalf-year Report
27th Aug 20213:15 pmRNSStatement re Net Asset Value and Fundraising
25th Jun 20219:32 amRNSTransaction in Own Shares
15th Jun 20211:30 pmRNS1st Quarter Results
10th Jun 20211:25 pmRNSResult of AGM
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 20212:44 pmRNSAnnual Financial Report
11th Mar 20212:52 pmRNSDirector/PDMR Shareholding
11th Mar 20212:51 pmRNSIssue of Equity and Close of Offer
5th Mar 20219:14 amRNSPayment of dividend and issue of equity
3rd Mar 20219:55 amRNSClose of Offer to Further Applications
22nd Feb 20214:15 pmRNSUpdate on Offer
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
27th Jan 20218:42 amRNSDividend Declaration
15th Dec 202011:42 amRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNS3rd Quarter Results
28th Sep 20207:15 amRNSTransaction in Own Shares
28th Sep 20207:14 amRNSDirectorate Change
21st Sep 202010:03 amRNSPayment of Dividend and Issue of Equity
12th Aug 20202:02 pmRNSReplacement Half-year Report to 30 June 2020
12th Aug 202010:15 amRNSHalf-year Report to 30 June 2020
29th Jun 202011:53 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSInterim Management Statement
16th Jun 20203:52 pmRNSResult of Annual General Meeting
28th May 20208:25 amRNSAnnual General Meeting
12th May 202012:49 pmRNSPayment of Dividend (amended)
12th May 20209:00 amRNSPayment of Dividend
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSTransaction in Own Shares
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
20th Mar 20209:41 amRNSAnnual Financial Report
19th Dec 201910:17 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.